[1]
|
Bain, B.J. (2010) Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1. Haematologica, 95, 696-698. http://dx.doi.org/10.3324/haematol.2009.021675
|
[2]
|
Valent, P., Horny, H.P., Bochner, B.S., Haferlach, T. and Reiter, A. (2012) Controversies and Open Questions in the Definitions and Classification of the Hypereosinophilic Syndromes and Eosinophilic Leukemias. Seminars in Hematology, 49, 171-181. http://dx.doi.org/10.1053/j.seminhematol.2012.01.009
|
[3]
|
Bain, B.J., Gilliland, D.G., Vardiman, J.W. and Horny, H.P. (2008) Chronic Eosinophilic Leukemia, Not Otherwise Specified. In: Swerdlow, S.H.C., Campo, E., Harris, N.L., et al., Eds., World Health Organization (WHO) Classification of Tumours, IARC Press, Lyon, 51-53.
|
[4]
|
Bain, B.J., Gilliland, D.G., Vardiman, J.W. and Horny, H.P. (2008) Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1. In: Swerdlow, S.H.C., Campo, E., Harris, N.L., et al., Eds., World Health Organization (WHO) Classification of Tumours, IARC Press, Lyon, 51-53.
|
[5]
|
Macdonald, D., Aguiar, R.C., Mason, P.J., Goldman, J.M. and Cross, N.C. (1995) A New Myeloproliferative Disorder Associated with Chromosomal Translocations Involving 8p11: A Review. Leukemia, 9, 1628-1630.
|
[6]
|
Chen, J., Deangelo, D.J., Kutok, J.L., Williams, I.R., Lee, B.H., Wadleigh, M., Duclos, N., Cohen, S., Adelsperger, J., Okabe, R., Coburn, A., Galinsky, I., Huntly, B., Cohen, P.S., Meyer, T., Fabbro, D., Roesel, J., Banerji, L., Griffin, J.D., Xiao, S., Fletcher, J.A., Stone, R.M. and Gilliland, D.G. (2004) PKC412 Inhibits the Zinc Finger 198-Fibroblast Growth Factor Receptor 1 Fusion Tyrosine Kinase and Is Active in Treatment of Stem Cell Myeloproliferative Disorder. Proceedings of the National Academy of Sciences, 101, 14479-14484. http://dx.doi.org/10.1073/pnas.0404438101
|
[7]
|
Hatzimichael, E., Georgiou, G., Benetatos, L. and Briasoulis, E. (2013) Gene Mutations and Molecularly Targeted Therapies in Acute Myeloid Leukemia. American Journal of Blood Research, 3, 29-51.
|
[8]
|
Savage, N., George, T.I. and Gotlib, J. (2013) Myeloid Neoplasms Associated with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, and FGFR1: A Review. International Journal of Laboratory Hematology, 35, 491-500.
|
[9]
|
Erba, H.P. (2010) Has There Been Progress in the Treatment of Older Patients with Acute Myeloid Leukemia? Best Practice Research Clinical Haematology, 23, 495-501. http://dx.doi.org/10.1016/j.beha.2010.09.012
|
[10]
|
Jackson, C.C., Medeiros, L.J. and Miranda, R.N. (2010) 8p11 Myeloproliferative Syndrome: A Review. Human Pathology, 41, 461-476. http://dx.doi.org/10.1016/j.humpath.2009.11.003
|
[11]
|
Valent, P., Gleich, G.J., Reiter, A., Roufosse, F., Weller, P.F., Hellmann, A., Metzgeroth, G., Leiferman, K.M., Arock, M., Sotlar, K., Butterfield, J.H., Cerny-Reiterer, S., Mayerhofer, M., Vandenberghe, P., Haferlach, T., Bochner, B.S., Gotlib, J., Horny, H.P., Simon, H.U. and Klion, A.D. (2012) Pathogenesis and Classification of Eosinophil Disorders: A Review of Recent Developments in the Field. Expert Review of Hematology, 5, 157-176. http://dx.doi.org/10.1586/ehm.11.81
|
[12]
|
Gotlib, J., Berube, C., Growney, J.D., Chen, C.C., George, T.I., Williams, C., Kajiguchi, T., Ruan, J., Lilleberg, S.L., Durocher, J.A., Lichy, J.H., Wang, Y., Cohen, P.S., Arber, D.A., Heinrich, M.C., Neckers, L., Galli, S.J., Gilliland, D.G. and Coutre, S.E. (2005) Activity of the Tyrosine Kinase Inhibitor PKC412 in a Patient with Mast Cell Leukemia with the D816V KIT Mutation. Blood, 106, 2865-2870. http://dx.doi.org/10.1182/blood-2005-04-1568
|
[13]
|
Fabbro, D., Ruetz, S., Bodis, S., Pruschy, M., Csermak, K., Man, A., Campochiaro, P., Wood, J., O’Reilly, T. and Meyer, T. (2000) PKC412—A Protein Kinase Inhibitor with a Broad Therapeutic Potential. Anti-Cancer Drug Design, 15, 17-28.
|
[14]
|
Marte, B.M., Meyer, T., Stabel, S., Standke, G.J., Jaken, S., Fabbro, D. and Hynes, N.E. (1994) Protein Kinase C and Mammary Cell Differentiation: Involvement of Protein Kinase C Alpha in the Induction of Beta-Casein Expression. Cell Growth Differentiation, 5, 239-247.
|
[15]
|
Growney, J.D., Clark, J.J., Adelsperger, J., Stone, R., Fabbro, D., Griffin, J.D. and Gilliland, D.G. (2005) Activation Mutations of Human c-KIT Resistant to Imatinib Mesylate Are Sensitive to the Tyrosine Kinase Inhibitor PKC412. Blood, 106, 721-724. http://dx.doi.org/10.1182/blood-2004-12-4617
|
[16]
|
Weisberg, E., Boulton, C., Kelly, L.M., Manley, P., Fabbro, D., Meyer, T., Gilliland, D.G. and Griffin, J.D. (2002) Inhibition of Mutant FLT3 Receptors in Leukemia Cells by the Small Molecule Tyrosine Kinase Inhibitor PKC412. Cancer Cell, 1, 433-443. http://dx.doi.org/10.1016/S1535-6108(02)00069-7
|